Compugen Ltd.
Organization details
- Legal name
- Compugen Ltd.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Israel
- Headquarters city
- Holon
- Headquarters country
- Israel
- Fiscal year end
- December
- Ticker symbol
- CGEN
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001119774
Board of directors
-
Anat Cohen-Dayag · DirectorSince 2026
-
Eran Ophir · Director · President and CEOSince 2026
-
Eran Perry · DirectorSince 2026
-
Gilead Halevy · DirectorSince 2026
-
Mathias Hukkelhoven · DirectorSince 2026
-
Michele Holcomb · DirectorSince 2026
-
Sanford S. Zweifach · DirectorSince 2026
-
Savitzky Kinneret Livnat · DirectorSince 2026
Chief executives
Board connections
1 of this board's directors also sit on 1 other board.
- via Michele Holcomb
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $118,301
- 11 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 29, 2026 | Mahler Michelle Officer (Chief Medical Officer) | Grant or award | +13,500 | — | — |
| Jul 29, 2026 | Sanford S. Zweifach Director | Grant or award | +7,500 | — | — |
| Jul 29, 2026 | Gilead Halevy Director | Grant or award | +7,500 | — | — |
| Jul 29, 2026 | Mathias Hukkelhoven Director | Grant or award | +7,500 | — | — |
| Jul 29, 2026 | Savitzky Kinneret Livnat Director | Grant or award | +7,500 | — | — |
| Jul 29, 2026 | Kredo Russo Sharon Officer (SVP, Research & Discovery) | Grant or award | +18,000 | — | — |
| Jul 29, 2026 | Eran Perry Director | Grant or award | +7,500 | — | — |
| Jul 29, 2026 | David Silberman Officer (Chief Financial Officer) | Grant or award | +19,500 | — | — |
| Jul 29, 2026 | Levine Zurit Officer (SVP, Business Development) | Grant or award | +18,000 | — | — |
| Jul 9, 2026 | Levine Zurit Officer (SVP, Business Development) | Option exercise | +1,875 | $0.83 | $1,556 |
| Jul 9, 2026 | Levine Zurit Officer (SVP, Business Development) | Open-market sale | −1,875 | $2.50 | $4,688 |
| Apr 24, 2026 | Levine Zurit Officer (SVP, Business Development) | Option exercise | +2,000 | $1.15 | $2,300 |
| Apr 24, 2026 | Eran Ophir Director, Officer (President and CEO) | Option exercise | +5,000 | $0.83 | $4,150 |
| Apr 24, 2026 | Levine Zurit Officer (SVP, Business Development) | Open-market sale | −2,000 | $3.20 | $6,400 |
| Apr 24, 2026 | Eran Ophir Director, Officer (President and CEO) | Open-market sale | −5,000 | $3.20 | $16,000 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Compugen Ltd.
Who is the CEO of Compugen Ltd.?
Eran Ophir has been Compugen Ltd.'s President and CEO since March 2026.
How many directors are on Compugen Ltd.'s board?
Compugen Ltd.'s board has 8 directors: Anat Cohen-Dayag, Eran Ophir, Eran Perry, Gilead Halevy, Mathias Hukkelhoven, Michele Holcomb, Sanford S. Zweifach and Savitzky Kinneret Livnat.
Are Compugen Ltd. insiders buying or selling shares?
Over the last 12 months, Compugen Ltd. insiders made no open-market purchases and sold $118,301 of shares in 11 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="compugen-ltd"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.